ホーム › 非ホジキンリンパ腫 › ペンシルベニア › Philadelphia
Philadelphia、PAにおける非ホジキンリンパ腫の臨床試験
Philadelphiaとその周辺地域（約30マイル以内）の拠点で、非ホジキンリンパ腫に関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
被験者募集中観察研究
- Children's Hospital of Philadelphia, Philadelphia
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- Fox Chase Cancer Center, Philadelphia
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
被験者募集中第1相
- University of Pennsylvania Abramson Cancer Center, Philadelphia
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
被験者募集中第1/2相
- Research Site, Philadelphia
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
被験者募集中第2相
- Research Site, Philadelphia
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
被験者募集中第1相
- Hospital of the University of Pennsylvania, Philadelphia
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
被験者募集中第1/2相
- Thomas Jefferson University, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
被験者募集中第1/2相
- Children's Hospital of Philadelphia, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
被験者募集中第1/2相
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
被験者募集中第1相
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Children's Hospital of Philadelphia, Philadelphia
- Nemours - Alfred I. duPont Hospital for Children, Brandywine · 21マイル先
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
被験者募集中第1相
- Abramson Cancer Center, University of Pennsylvania, Philadelphia
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
被験者募集中第1/2相
- Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
Epcoritamab-CAR T Cells for Large B-cell Lymphomas
被験者募集中第2相
- Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
被験者募集中第1/2相
- Children's Hospital of Philadelphia, Philadelphia
SynKIR-310 for Relapsed/Refractory B-NHL
被験者募集中第1相
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
被験者募集中第4相
- University of Pennsylvania Hospital, Philadelphia
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
被験者募集中第4相
- University of Pennsylvania Hospital, Philadelphia
Mozobil for Autologous Hematopoietic Stem Cell Transplantation
被験者募集中第2相
- Thomas Jefferson University Hospital, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Philadelphia
他の都市における非ホジキンリンパ腫の試験
- New York City, NY31件の研究
- Houston, TX31件の研究
- Boston, MA26件の研究
- Nashville, TN21件の研究
- Baldwin Park, CA19件の研究
- Washington, DC18件の研究
- Atlanta, GA18件の研究
- Chicago, IL18件の研究
- Milwaukee, WI18件の研究
- Columbus, OH18件の研究
- Dallas, TX17件の研究
- Seattle, WA16件の研究
Philadelphiaにおける他の研究
- がん（全種類）59件の研究
- 乳がん56件の研究
- 非小細胞肺癌51件の研究
- 転移性癌46件の研究
- 前立腺がん44件の研究
- 大腸癌44件の研究
- 卵巣がん44件の研究
- 肺がん36件の研究
- 急性骨髄性白血病34件の研究
- 心不全31件の研究
- 子宮内膜がん28件の研究
- うつ病26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。